Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer. Issue 2 (December 2015) - Mace, Thomas; Shakya, Reena; Pitarresi, Jason; Loftus, Shannon; Swanson, Benjamin; Young, Gregory; Zhong, Xioling; Zimmers, Teresa; Ostrowski, Michael; Ludwig, Thomas; Bloomston, Mark; Bekaii-Saab, Tanios; et al.